Duration of Upfront Immunotherapy for NSCLC – OncLive
OncLive |
Duration of Upfront Immunotherapy for NSCLC
OncLive Everett Vokes, MD: We've covered a lot of the key studies. There are a lot of unanswered questions, of course. We covered where PD-L1-negative or low expressers fall into this, and we're waiting for more data. Another issue is the duration of therapy … |
